Preclinically, administration of lentivirus-mediated short hairpin RNA (shRNA) targeting GAS6-AS1 considerably suppresses acute myeloid leukemia cell propagation and disease progression, indicating the crucial roles of GAS6-AS1/YBX1/MYC axis in leukemia. Here, YBX1 is linked to acute myeloid leukemia.